A single treatment with gene therapy normalized levels of Factor VIII in patients with hemophilia as long as 1 year after the infusion, according to a study in the New England Journal of Medicine.
Read more via Qmul.ac.uk and access the study at Nejm.org.
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
